Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies
β Scribed by Paul K.S. Chan; Alexander R. Chang; Mei Y. Yu; Wai-Hon Li; May Y.M. Chan; Apple C.M. Yeung; Tak-Hong Cheung; Tat-Nga Yau; Sze-Man Wong; Ching-Wai Yau; Ho-Keung Ng
- Book ID
- 102271780
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 172 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Although a second ageβrelated peak of human papillomavirus (HPV) infection is observed in many populations, it does not seem to have any impact on cervical screening policies. We examined the ageβspecific prevalence of HPV infection among 2,604 women enrolled for cervical screening and correlated the age at diagnosis of 2,491 cervical intraepithelial neoplasia Grade 2/3 (CIN2/3) lesions and 801 invasive cervical cancers (ICC). Two peaks of HPV infection were detected at 26β30 and 46β50 years, respectively. The first infection peak was followed by a CIN2/3 peak and an ICC peak at 5β15 and 15 years later, respectively. The second infection peak was followed by an ICC peak 20 years later, but strikingly no CIN2/3 peak was detected in between and thus eliminated an opportunity of treating the lesions at preinvasive stages. The most plausible explanation is that women at the expected second CIN2/3 peak (50β65 years) are not having Pap smears under the current opportunistic screening program. Furthermore, women of this age may have physiological retraction of the transformation zone, and CIN lesions may remain undetected if an adequate Pap smear sample is not obtained. To combat this problem, the screening program in Hong Kong needs to focus on women aged 50 years and older and a mopβup screening up to 75 years is necessary. Bimodal peaks of HPV infection and cervical cancer are seen in many countries and the analysis of populationβspecific age distribution of CIN2/3 should be an integral exercise in evaluating the effectiveness of a screening program.
π SIMILAR VOLUMES
## Abstract Infection with highβrisk human papillomavirus (HPV) causes cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC). The distribution of HPV types in cervical diseases has been previously described in small studies for Canadian women. The prevalence of 36 HPV genotype